Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 702

1.

IL-7-mediated protection against minor-antigen-mismatched allograft rejection is associated with enhanced recovery of regulatory T cells.

Broers AE, Bruinsma M, Posthumus-van Sluijs SJ, Wils EJ, Spits H, Löwenberg B, Braakman E, Cornelissen JJ.

Haematologica. 2007 Aug;92(8):1099-106.

2.

CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.

Atanackovic D, Cao Y, Luetkens T, Panse J, Faltz C, Arfsten J, Bartels K, Wolschke C, Eiermann T, Zander AR, Fehse B, Bokemeyer C, Kroger N.

Haematologica. 2008 Mar;93(3):423-30. doi: 10.3324/haematol.11897. Epub 2008 Feb 20.

3.

Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.

Xia G, He J, Leventhal JR.

Am J Transplant. 2008 Feb;8(2):298-306. doi: 10.1111/j.1600-6143.2007.02088.x. Epub 2008 Jan 7.

4.

The role of Foxp3+ regulatory T cells in liver transplant tolerance.

Li W, Carper K, Zheng XX, Kuhr CS, Reyes JD, Liang Y, Perkins DL, Thomson AW, Perkins JD.

Transplant Proc. 2006 Dec;38(10):3205-6.

PMID:
17175223
5.

Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.

Oderup C, Malm H, Ekberg H, Qi Z, Veress B, Ivars F, Corbascio M.

Transplantation. 2006 Dec 15;82(11):1493-500.

PMID:
17164722
6.

Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.

Alpdogan O, Schmaltz C, Muriglan SJ, Kappel BJ, Perales MA, Rotolo JA, Halm JA, Rich BE, van den Brink MR.

Blood. 2001 Oct 1;98(7):2256-65.

8.

Keratinocyte growth factor improves allogeneic bone marrow engraftment through a CD4+Foxp3+ regulatory T cell-dependent mechanism.

Bruinsma M, van Soest PL, Leenen PJ, Löwenberg B, Cornelissen JJ, Braakman E.

J Immunol. 2009 Jun 15;182(12):7364-9. doi: 10.4049/jimmunol.0803253.

9.

Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.

He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.

Surgery. 2009 Jun;145(6):663-74. doi: 10.1016/j.surg.2009.01.016. Epub 2009 Apr 19.

PMID:
19486771
10.

Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.

Xia G, He J, Zhang Z, Leventhal JR.

Transplantation. 2006 Dec 27;82(12):1749-55.

PMID:
17198271
11.

[Effect of Rapamycin on CD4(+) CD25(+) regulatory T cells in allo-transplantation tolerance model].

Zheng YX, Hou GH, Song J, Zhang C, Liang T.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Apr;23(4):327-30. Chinese.

PMID:
17428387
12.

A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.

Choksi S, Kim JC, Whitaker-Menezes D, Murphy GF, Friedman TM, Korngold R.

Biol Blood Marrow Transplant. 2004 Oct;10(10):669-80.

13.

Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioning.

Kim YM, Mapara MY, Down JD, Johnson KW, Boisgerault F, Akiyama Y, Benichou G, Pelot M, Zhao G, Sykes M.

Blood. 2004 Jan 15;103(2):732-9. Epub 2003 Sep 25.

14.

Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy.

Feng G, Wood KJ, Bushell A.

Transplantation. 2008 Aug 27;86(4):578-89. doi: 10.1097/TP.0b013e3181806a60.

PMID:
18724229
15.

Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.

Wang S, Jiang J, Guan Q, Lan Z, Wang H, Nguan CY, Jevnikar AM, Du C.

Transpl Immunol. 2008 May;19(2):93-102. doi: 10.1016/j.trim.2008.03.004. Epub 2008 Apr 28.

PMID:
18503884
17.
18.

An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD.

Petrus MJ, Williams JF, Eckhaus MA, Gress RE, Fowler DH.

Biol Blood Marrow Transplant. 2000;6(2A):182-9.

PMID:
10816026
19.

Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.

He KM, Ma Y, Wang S, Min WP, Zhong R, Jevnikar A, Zhang ZX.

Eur J Immunol. 2007 Dec;37(12):3455-66.

Items per page

Supplemental Content

Write to the Help Desk